drugset / Trial / NCT02918279

Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity

NCT02918279

Phase 3 Completed 251 enrolled Novo Nordisk A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial is conducted globally. The aim of this trial is to investigate the effect of liraglutide for weight management in pubertal adolescent subjects with obesity.

Timeline

Start
2016-09-29
Primary completion
2019-02-14
Completion
2019-08-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Liraglutide Peptide 3 mg Subcutaneous